Showing results (1831-1840 of 2,360) with videos related to
Sort By:
Pageof 236
Human Mutation|September 23, 1998
Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype-phenotype correlationsI Dianzani, L de Sanctis, P M Smooker, et al.ACS Applied Materials & Interfaces|July 27, 2023
Effect of Additives on the Surface Morphology, Energetics, and Contact Resistance of PEDOT:PSSAlexander X Chen, Guillermo L Esparza, Ignasi Simon, et al.ACS Nano|January 6, 2016
Production of Highly Monolayer Enriched Dispersions of Liquid-Exfoliated Nanosheets by Liquid Cascade CentrifugationClaudia Backes, Beata M Szydłowska, Andrew Harvey, et al.Cell Communication and Signaling : CCS|August 7, 2013
The cytohesin paralog Sec7 of Dictyostelium discoideum is required for phagocytosis and cell motilityRolf Müller, Claudia Herr, Salil K Sukumaran, et al.Oncotarget|November 22, 2017
Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trialMichael Schmitt, Angela G Hückelhoven, Michael Hundemer, et al.Haematologica|December 5, 2024
Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell TherapyWolfgang Bethge, Sarah Flossdorf, Franziska Hanke, et al.Plant Physiology|February 22, 2019
Deficiency in the Phosphorylated Pathway of Serine Biosynthesis Perturbs Sulfur AssimilationArmand D Anoman, María Flores-Tornero, Ruben M Benstein, et al.JAMA Oncology|June 5, 2018
Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical TrialGuy Jerusalem, Richard H de Boer, Sara Hurvitz, et al.Respiratory Medicine|September 27, 2017
Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experienceAdi Dagan, Malena Cohen-Cymberknoh, Michal Shteinberg, et al.Nature Communications|January 4, 2018
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancerHadas Gibori, Shay Eliyahu, Adva Krivitsky, et al.Pageof 236